These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6340975)

  • 21. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eimer M; Cable T; Gal P; Rothenberger LA; McCue JD
    J Fam Pract; 1985 Nov; 21(5):359-62. PubMed ID: 2865326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of increasing doses of beta-agonists on airflow in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Cook D; Morris J; Willan A; McIlroy W; Harper S; Ramsdale H; Haddon R; Fitzgerald MJ
    Respir Med; 1993 Aug; 87(6):433-8. PubMed ID: 8105519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of high-dose ipratropium bromide and oral aminophylline on spirometry and exercise tolerance in COPD.
    Shivaram U; Cash ME; Mateo F; Shim C
    Respir Med; 1997 Jul; 91(6):327-34. PubMed ID: 9282234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
    Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
    Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breathlessness and portable oxygen in chronic obstructive airways disease.
    Waterhouse JC; Howard P
    Thorax; 1983 Apr; 38(4):302-6. PubMed ID: 6867984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the effects of salmeterol and ipratropium bromide on exercise performance and breathlessness in patients with stable chronic obstructive pulmonary disease.
    Patakas D; Andreadis D; Mavrofridis E; Argyropoulou P
    Respir Med; 1998 Sep; 92(9):1116-21. PubMed ID: 9926165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease.
    Hadcroft J; Calverley PM
    Thorax; 2001 Sep; 56(9):713-20. PubMed ID: 11514693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The additive effect of theophylline on a high-dose combination of inhaled salbutamol and ipratropium bromide in stable COPD.
    Nishimura K; Koyama H; Ikeda A; Sugiura N; Kawakatsu K; Izumi T
    Chest; 1995 Mar; 107(3):718-23. PubMed ID: 7874943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbimazole and exercise tolerance in chronic airflow obstruction.
    Butland RJ; Pang JA; Geddes DM
    Thorax; 1982 Jan; 37(1):64-7. PubMed ID: 7041324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of salmeterol in stable COPD.
    Kaushik ML; Kashyap S; Bansal SK; Sharma A
    Indian J Chest Dis Allied Sci; 1999; 41(4):207-12. PubMed ID: 10661008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
    Ulrik CS
    Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clenbuterol and salbutamol in the symptomatic treatment of patients with reversible airways obstruction.
    Jaffé G; Grimshaw JJ
    Pharmatherapeutica; 1983; 3(7):492-5. PubMed ID: 6366806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction.
    Taylor DR; Buick B; Kinney C; Lowry RC; McDevitt DG
    Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Willan A; Cook D; Harper S; Morris J; Ramsdale H; Haddon R; Newhouse M
    Thorax; 1994 May; 49(5):479-84. PubMed ID: 8016770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinico-pharmacologic study of a new sustained-release oral salbutamol preparation in patients with obstructive airway disease].
    Bauer K; Lorenz PR; Seibel K; Neiss A; Eandi M; Kaik G
    Arzneimittelforschung; 1989 Jul; 39(7):801-4. PubMed ID: 2675854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose response to inhaled salbutamol in chronic obstructive airways disease.
    Teale C; Morrison JF; Page RL; Pearson SB
    Postgrad Med J; 1991 Aug; 67(790):754-6. PubMed ID: 1754527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplifying the assessment of patients with chronic airflow limitation for home nebulizer therapy.
    Goldman JM; Teale C; Muers MF
    Respir Med; 1992 Jan; 86(1):33-8. PubMed ID: 1533047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.